Ascentage Pharma Group International (HKG:6855)

HKG:6855 Revenue

Ascentage Pharma Group International had revenue of 823.75M CNY in the half year ending June 30, 2024, with 760.19% growth. This brings the company's revenue in the last twelve months to 903.03M, up 251.85% year-over-year. In the year 2023, Ascentage Pharma Group International had annual revenue of 221.98M with 5.85% growth.

• Revenue (ttm): 903.03M CNY
• Revenue Growth: +251.85%
• P/S Ratio: 11.17
• Revenue / Employee: 1.55M CNY
• Employees: 583
• Market Cap: 12.76B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	221.98M	12.27M	5.85%
Dec 31, 2022	209.71M	181.80M	651.38%
Dec 31, 2021	27.91M	15.46M	124.18%
Dec 31, 2020	12.45M	-2.06M	-14.21%
Dec 31, 2019	14.51M	7.71M	113.21%